Sophiris competitorsClear all

Sophiris's top competitors include Cantabio Pharmaceuticals, Roche, Bristol-Myers Squibb and AstraZeneca.
Sophiris
Sophiris
Sophiris is a Canada-based biopharmaceutical company focused on the research, development and commercialization of products for the treatment of urological diseases.
Cantabio Pharmaceuticals
Cantabio Pharmaceuticals
Cantabio Pharmaceuticals Inc. is a biotechnology company focusing on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson’s disease (PD), Alzheimer’s disease (AD) and other related neurodegenerative diseases.
Roche
Roche
Roche Holding is a diagnostics and pharmaceutical company.
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases.
AstraZeneca
AstraZeneca
AstraZeneca is a global biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
Founding Date
Founding Date
2002
Founding Date
2009
Founding Date
1896
Founding Date
1887
Founding Date
1999
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
Sunnyvale, US HQ
Locations
Basel, CH HQ
Hydra, DZ
Ricardo Rojas, AR
Bella Vista, AU
North Ryde, AU
Sydney, AU
Wien, AT
see more
Locations
New York, US HQ
Braine L'alleud, BE
Montréal, CA
Montréal, CA
Pudong Xinqu, CN
Virum, DK
Espoo, FI
see more
Locations
Cambridge, GB HQ
Tizi Ouzou, DZ
Sidi M'hamed, DZ
Buenos Aires, AR
Macquarie Park, AU
Vienna, AT
Cotia, BR
see more
Employees
Employees
6
Employees
11
Employees
94,4421% increase
Employees
23,3002% decrease
Employees
61,100
Valuation ($)
Valuation ($)
23.1 m
Valuation ($)
1.1 m
Valuation ($)
N/A
Valuation ($)
75.3 b
Valuation ($)
103.9 b
Twitter followers
Twitter followers
152
Twitter followers
1.1 k
Twitter followers
196 k
Twitter followers
133.5 k
Twitter followers
159.4 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
96
Number of tweets (last 30 days)
37
Number of tweets (last 30 days)
56
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
9.6
Average likes per tweet (last 30 days)
35.6
Average likes per tweet (last 30 days)
12.1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
81.25%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
220153
Alexa Website Rank
872567
Alexa Website Rank
74758
Alexa Website Rank
170410
Alexa Website Rank
132544

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
CHF48.1b (FY, 2015)
Revenue (est.)
$22.6b (FY, 2018)
Revenue (est.)
£16.9b (FY, 2018)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
CHF15.5b (FY, 2015)
Cost of goods
N/A
Cost of goods
£3.8b (FY, 2018)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
CHF32.7b (FY, 2015)
Gross profit
N/A
Gross profit
£13.1b (FY, 2018)
Net income
Net income
($6.8m) (FY, 2018)
Net income
($2m) (FY, 2018)
Net income
CHF9.1b (FY, 2015)
Net income
$4.9b (FY, 2018)
Net income
£1.6b (FY, 2018)

Operating

Drugs Approved by FDA
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Drugs Approved by FDA
2 (Y, 2015)
Drugs Approved by FDA
N/A
Drugs Approved by FDA
1 (FY, 2015)
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
8 (FY, 2016)
Phase III Trials Products
27 (FY, 2016)
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
44 (FY, 2016)
Projects in R&D Pipeline
132 (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 47.2m
Total funding raised
N/A
Total funding raised
$ 2.8b
Total funding raised
$ 15.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Cantabio Pharmaceuticals
HQ
Sunnyvale, US
Employees
11

Cantabio Pharmaceuticals Inc. is a biotechnology company focusing on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson’s disease (PD), Alzheimer’s disease (AD) and other related neurodegenerative diseases.

View company
Roche
HQ
Basel, CH
Employees
94,442↑ 1% increase

Roche Holding is a diagnostics and pharmaceutical company.

View company
Bristol-Myers Squibb
HQ
New York, US
Employees
23,300↓ 2% decrease

Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases.

View company
AstraZeneca
HQ
Cambridge, GB
Employees
61,100

AstraZeneca is a global biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.

View company